Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-002291-41Phase 4Completed
Phase 4, single-arm trial of phytomenadione, sponsored by Hospital Gelderse Vallei. Primary endpoints: Prothrombin (factor II) activity at day of invasive procedure and Factor VII activity at day of invasive procedure. Started Aug 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-002291-41.